Clinical Trials Browser

Phase 2 × Completed × Multiple Sclerosis × Clear all

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT02591901 2020-03-18

PReSuTINeB

Phase 2 Completed

48 enrolled

Genitourinary

Urinary Bladder, Neurogenic, Multiple Sclerosis, Myelitis, Transverse, Spinal Cord Injuries, Urinary Tract Infections

Clinical Trials

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

PReSuTINeB